바이오로직스 자료
Innovative approaches to enhance cell culture density for high-quality production
Recent innovations in intensified fed-batch (IFB) processing have led to substantial improvements in cell culture yields and scalability, driving more efficient biopharmaceutical production. Watch our on-demand webinar, in collaboration with BPI, where our upstream process development scientists discuss the latest advancements in IFB processing and how our S-Tensify™ platform ensures consistent quality and productivity.
Key Takeaways:
- Learn how Samsung Biologics integrated intensified fed-batch (IFB) processing to achieve higher densities of viable cells during the N-1 step.
- Discover how Samsung Biologics’ IFB platform, S-Tensify™, optimizes cell culture processes, enhancing yield and material quality.
- Explore case studies that demonstrate a 30-fold increase in inoculation cell density using the S-Tensify™ platform.
Recent innovations in intensified fed-batch (IFB) processing have led to substantial improvements in cell culture yields and scalability, driving more efficient biopharmaceutical production. Watch our on-demand webinar, in collaboration with BPI, where our upstream process development scientists discuss the latest advancements in IFB processing and how our S-Tensify™ platform ensures consistent quality and productivity.
Key Takeaways:
- Learn how Samsung Biologics integrated intensified fed-batch (IFB) processing to achieve higher densities of viable cells during the N-1 step.
- Discover how Samsung Biologics’ IFB platform, S-Tensify™, optimizes cell culture processes, enhancing yield and material quality.
- Explore case studies that demonstrate a 30-fold increase in inoculation cell density using the S-Tensify™ platform.
